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Abstract
While not itself life-threatening, ductal carcinoma in situ (DCIS) can progress to invasive disease 
if untreated, and confers an increased risk of future breast cancer. We investigated knowledge of 
DCIS among a cohort of English- and Spanish-speaking Latina and English-speaking non-Latina 
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white women previously treated for DCIS. We examined knowledge of DCIS with four true/false 
statements about risk of invasive disease, breast cancer recurrence, and prognosis. For each 
knowledge statement, we modeled the odds of a correct answer by language–ethnicity (English-
speaking Latinas, Spanish-speaking Latinas, and English-speaking whites) adjusting for 
demographics, health history, and treatment factors. Of 710 participants, 52 % were English-
speaking whites, 21 % English-speaking Latinas, and 27 % Spanish-speaking Latinas. Less than 
half (41 %) of participants were aware that DCIS is not life-threatening and only 32 % knew that 
surgical treatment choice does not impact mortality; whereas two-thirds (67 %) understood that 
DCIS confers increased risk of future breast cancer, and almost all (92 %) knew that DCIS, if 
untreated, could become invasive. Only three Spanish-speakers used professional interpreters 
during discussions with their physicians. In adjusted analyses, compared to English-speaking 
whites, both English- and Spanish-speaking Latinas had significantly lower odds of knowing that 
DCIS was not life-threatening (OR, 95 % CI 0.6, 0.4–0.9 and 0.5, 0.3–0.9, respectively). In 
contrast, Spanish-speaking Latinas had a twofold higher odds of knowing that DCIS increases risk 
of future breast cancer (OR, 95 % CI 2.6, 1.6–4.4), but English-speaking Latinas were no different 
from English-speaking whites. Our data suggest that physicians are more successful at conveying 
the risks conferred by DCIS than the nuances of DCIS as a non-life-threatening diagnosis. This 
uneven communication is most marked for Spanish-speaking Latinas. In addition to the use of 
professional interpreters, efforts to create culturally and linguistically standardized information 
could improve knowledge and engagement in informed decision making for all DCIS patients.
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Background
Since the advent of mammographic screening for breast cancer, ductal carcinoma in situ 
(DCIS) has become a common diagnosis, accounting for almost one-third of 
mammographically diagnosed breast cancers [1, 2]. Recent data from the California Cancer 
Registry indicate an increase in the incidence of DCIS among Latina women from 
9.6/100,000 in 1990 to 19.5/100,000 in 2009 and an increase in incidence among non-Latina 
white women from 20.2/100,000 in 1990 to 35.1/100,000 in 2009 [3]. While DCIS is not 
life-threatening and is highly curable, it can progress to invasive disease if left untreated and 
does confer an increased risk of future breast cancer. Evidence suggests that up to 50 % of 
untreated DCIS may progress to invasive breast cancer over a women’s lifetime [4].
The primary goal of DCIS treatment is to prevent invasive breast cancer [5]. Treatment 
options include mastectomy which is associated with a recurrence rate of only 1 % or breast-
conserving surgery (BCS), with or without radiation therapy. BCS has comparable survival 
rates to mastectomy but has higher rates of local recurrence, particularly without radiation 
therapy [6–8]. Hormonal therapy may also be recommended for some DCIS patients [9]. 
Given the range of therapeutic options and the decisions required to determine the optimal 
treatment approach, patients need a clear understanding of the risk implications of a DCIS 
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diagnosis in order to make informed treatment decisions. However, communicating the risk 
implications of DCIS can be challenging due to their complexity [10].
One prior study demonstrated that although women with DCIS were satisfied with their 
care, there were significant gaps in women’s knowledge about their diagnosis. These 
knowledge gaps were particularly notable with regard to the course and severity of the 
disease, and understanding of future breast cancer risk. Participants in this study were from a 
single clinical site and were almost all white [11]. Two more recent studies from Australia 
also demonstrated a knowledge gap about the lack of metastatic potential of DCIS, finding 
that women who thought DCIS could metastasize were more likely to be worried about 
dying from DCIS [12, 13].
This already-complex communication challenge is further complicated when there exists a 
need to communicate health information across culture and language. Less acculturated 
Latinas are more likely to be worried about their breast cancer diagnosis and worry is 
associated with a poorer understanding of information [14]. Additionally, language barriers 
may impede Spanish-speaking women from asking all of their questions at the time of breast 
cancer diagnosis [15]. There is limited information about the knowledge of DCIS 
particularly among Latina women. In a prior multi-ethnic, multilingual study examining 
women’s knowledge of early-stage breast cancer, the authors found that only one-fifth of 
patients understood that there was a difference in recurrence rate between mastectomy and 
breast-conserving therapy and only half of patients knew that survival rates were equivalent 
across treatment strategies [16]. This study did not report results for women with DCIS 
separately from those with Stage I invasive breast cancer, nor did they report results 
separately for 8 % of the sample that was Latina.
Given the paucity of literature regarding the understanding of DCIS in Latina women, in the 
current study we sought to evaluate knowledge of DCIS among a cohort of English- and 
Spanish-speaking Latina and English-speaking non-Latina white women previously treated 
for DCIS. We hypothesized that due to a language barrier, Spanish-speaking Latinas would 
be least likely to know the risk implications of a DCIS diagnosis.
Methods
Study population and data collection
Data for this analysis were collected as part of an observational study designed to examine 
treatment decision-making, satisfaction, communication, and knowledge among Latina and 
non-Latina white women treated for DCIS. Details of participant recruitment and data 
collection have been published previously [17]. In brief, we identified potential participants 
through a statewide population-based cancer registry, the California Cancer Registry (CCR), 
representing 35 of 58 counties in California. Participants met the following inclusion 
criteria: (1) diagnosed with histologically confirmed DCIS in 2002–2005; (2) self-identified 
as Latina or non-Latina white; (3) English or Spanish-speaking; (4) 18 years of age or older; 
and (5) no subsequent diagnosis of invasive breast cancer. Study recruitment took place 
between January 2005 and September 2006. Within each region and county, all Latina 
women were sampled. Given the larger number of non-Latina white women, they were 
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selected randomly and matched to Latina cases by age (within 5-year increments), diagnosis 
period (within 6-month intervals), and county of diagnosis.
We conducted telephone interviews in English or Spanish according to the participant’s 
preference, approximately 24 months after initial diagnosis. This 24-month period was 
necessary to receive and process complete information from the CCR and to reach 
participants for interviews. The UCSF Committee on Human Research approved all study 
procedures and informed consent was obtained from all participants. Verbal informed 
consent was obtained before initiating the telephone interview. Bilingual interviewers were 
trained by the project director through extensive role-playing and were provided with 
structured scripts. English and Spanish structured interview scripts were used indicating the 
purpose of the interview while informing the participant that the interview was voluntary 
and that they could elect to stop the interview at any point.
Measures
Primary predictor: ethnicity–language—Participants were sampled according to 
ethnicity in the CCR: Latina or non-Latina white. We confirmed their ethnicity by self-
report at the time of enrollment. We additionally categorized Latinas as English-speaking or 
Spanish-speaking according to their preferred language of interview. Interview language, 
when compared for a subset of participants, was highly correlated with self-reported ability 
to speak English. Of the women who completed the interview in Spanish, 6.3 % reported 
that they spoke English well or very well.
Outcome: knowledge—We adapted a series of questions previously used to evaluate 
women’s knowledge of DCIS to focus on risk of future breast cancer and mortality [11]. 
Embedded within a series of questions about breast cancer, the following four statements 
about future breast cancer risk and mortality risk were presented to the patients with the 
response options of true/false/unsure: “This type of breast cancer is not itself life-
threatening,” “Women with this type of breast problem have more chances of developing 
breast cancer in the future,” “If untreated, this type of breast problem can become invasive 
cancer,” and “The chances of dying from the breast problem are the same for women who 
have a mastectomy and for those who have a lumpectomy with radiation.” The correct 
answer for each of these questions was “true.”
Demographic information
Women self-reported their educational attainment (less than high school/high school or 
vocational graduate/college or higher), current insurance status (public/private/no insurance/
unknown), and age at the time of interview. Since in California women without insurance 
coverage would have qualified for Medicaid during their breast cancer treatment, and very 
few women (n = 47) reported no or unknown insurance, we combined those categories with 
public insurance. For descriptive and analytic purposes, we combined the 35 CCR regions 
into five geographic areas in California according to the counties covered (Bay Area, 
Central and Sacramento, Los Angeles and Tri-County, Riverside and San Bernardino, and 
San Diego).
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DCIS treatment was documented in the CCR data and confirmed with women during their 
interview (mastectomy, lumpectomy without radiation, and lumpectomy with radiation). 
Three women who reported no treatment were not included in the analysis. We made this 
decision in order to be consistent with the methods in previous analyses of these data, and 
because our use of CCR data restricted us to reporting on groups of women. As only three 
women did not have treatment, this number did not represent a large enough group to report 
on separately. We asked women about their family history of breast cancer and categorized 
women as having an immediate relative (mother, sister, daughter, aunt, or grandmother), a 
distant relative, or no relative with breast cancer. As the number of women reporting a 
distant relative with breast cancer was small (n = 49), we combined those with a distant 
relative and those with no relative.
Diagnostic information
We asked women if they obtained a second opinion prior to their treatment for DCIS (yes/
no). We additionally recorded the time from diagnosis to the time of interview to account for 
possible variation in recall.
Statistical analysis
We compared demographic, health history, diagnostic information, and knowledge outcome 
variables by language–ethnicity group (English-speaking Latinas, Spanish-speaking Latinas, 
and English-speaking whites). We used descriptive statistics to report overall proportions 
and means, and Chi square and t-tests to compare the groups. For the knowledge outcomes, 
we described the proportion in each group answering each of the four questions yes, no, or 
unsure.
In multivariate analysis, we modeled the odds of giving a correct answer for each question 
by ethnicity–language group and surgical treatment type (combining lumpectomy with and 
without radiation as very few Latinas reported no radiation). We further adjusted for family 
history of breast cancer, educational attainment, age, insurance, geographic region in 
California, time between diagnosis and interview, and having sought out a second opinion.
Results
Of the 1,231 women eligible for the study, attempts to contact them resulted in 319 refusals, 
167 non-respondents, and 745 completed surveys. Whites had a higher completion rate than 
Latinas (67 % and 55 %, respectively) [17]. From this group of 745, a total of 710 patients 
answered the knowledge survey questions and were included in this study.
Sample characteristics
More than half of the sample was English-speaking whites (52 %), 21 % were English-
speaking Latinas and 27 % were Spanish-speaking Latinas. The mean age of the sample 
overall was 57 (range 27–78), with balanced proportions of women less than age 50, age 50–
64, and ≥age 65 in all groups (Table 1).
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Most of the white women reported having completed a college education, whereas most of 
the Spanish-speaking Latinas reported having completed less than a high school education. 
English-speaking Latinas reported a wider range of educational attainment. Most English-
speaking whites and English-speaking Latinas were privately insured, compared to only half 
of Spanish-speakers. The distribution of surgery type was similar across groups, although 
fewer English-speaking whites underwent radiation therapy. Spanish-speakers were less 
likely than women in the other groups to have had an immediate relative with breast cancer 
or to have obtained a second opinion.
Of the 190 Spanish-speaking Latina participants, 64 % reported having someone present to 
interpret for them while with their breast cancer physician. Of these, 50 % had a family 
member or friend interpret for them, 44 % had non-interpreter clinic staff (e.g., a nurse or 
clerk) interpret, and 3 % had a professional interpreter. Four participants did not report who 
did the interpreting.
Knowledge of DCIS
Overall, less than half (41 %) of the women were aware that DCIS is not life-threatening and 
only a third (32 %) knew that mortality risk is the same for mastectomy and lumpectomy 
plus radiation. By contrast, two-thirds (67 %) were aware that DCIS confers increased risk 
of future breast cancer, and almost all (92 %) knew that it could become invasive if not 
treated (Table 2).
English-speaking whites were most likely to know that DCIS is not life-threatening. 
Spanish-speaking Latinas were most likely to correctly assess that women with DCIS have a 
higher chance of developing breast cancer in the future and that the mortality from DCIS 
after mastectomy was similar to that after lumpectomy with radiation.
These results persisted in multivariable-adjusted analysis for knowledge of the life-
threatening nature of DCIS and risk of future breast cancer (Table 3). Compared with 
English-speaking whites, both English-speaking and Spanish-speaking Latinas had 
significantly lower odds of knowing that DCIS was not itself life-threatening (OR, 95 % CI 
0.6, 0.4–0.9 and 0.5, 0.3–0.9 respectively). In contrast, Spanish-speaking Latinas had more 
than twofold higher odds of knowing that DCIS increases risk of future breast cancer (OR, 
95 % CI 2.6, 1.6–4.4) while there was no difference in knowledge between English-speaking 
Latinas and English-speaking whites. Surgical treatment type was not independently 
associated with knowledge of any of the four items. None of the potential confounders 
except for age were associated with any of the knowledge outcomes. Age was associated 
with decreased odds of knowing the risk of future breast cancer (OR, 98 % CI 0.98, 0.96–
1.00).
Discussion
This multi-ethnic, multilingual study design provided an ideal opportunity to investigate 
patient–provider exchange of information regarding DCIS, a complex and often poorly 
communicated diagnosis.
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In this study of DCIS knowledge in a cohort of Latina and non-Latina white women, we 
hypothesized that Spanish-speaking Latinas would have poorer knowledge about the risks 
and prognosis related to DCIS than their English-speaking counterparts. However, our 
results reveal a more complicated scenario. Less than half of all women (41 %) 
demonstrated accurate knowledge about the long-term clinical impact of DCIS, even among 
those having attained a college education. While knowledge that DCIS is not itself life-
threatening was low in our study overall, both Spanish- and English-speaking Latinas were 
less likely to correctly answer this question when compared to white women. In contrast, 
Spanish-speaking Latinas were more likely than their English-speaking counterparts—both 
Latinas and whites—to know that a diagnosis of DCIS confers an increased risk of a breast 
cancer diagnosis in the future. There was no difference among groups in knowledge of the 
risk of invasive cancer if DCIS is left untreated—the vast majority of women in all groups 
were aware of this risk. There was also no difference in the understanding of DCIS 
treatment and mortality. The majority of women in all groups lacked an understanding of 
this relationship, with less than one-third of all women indicating that there was no impact 
on mortality based on treatment choice. Overall, these findings suggest that overall 
knowledge of the prognosis and treatment implications for DCIS are poorly understood. 
Among Spanish-speaking women diagnosed with DCIS, there appears to be a clear message 
from their physicians about the risks, but perhaps not about the good prognosis of DCIS.
Our findings are consistent with prior studies of primarily white women who have found 
knowledge gaps in those diagnosed with either DCIS or invasive breast cancer [11–13, 16]. 
Importantly, these and other studies have indicated that less knowledge is associated with 
more anxiety and distress [10, 13, 18]. One qualitative study by members of our group found 
that Latinas tend to have more distress about their diagnosis than whites [19]. Thorough 
information exchange has the potential to build positive relationships between patients and 
their providers and furthermore may help women build a sense of mastery over their breast 
cancer [20]. The lack of such an exchange likely contributes to less knowledge and more 
worry. These results complement other research by our team where we asked breast 
surgeons and oncologists about challenges in communicating prognosis with patients across 
language barriers. More than half of the breast cancer physicians surveyed expressed 
experiencing difficulty discussing prognosis with their limited English proficient (LEP) 
patients and the majority worried that their LEP patients might not be asking all of their 
questions during these discussions [15]. Together with our current findings that Spanish-
speaking women understand DCIS risks better than prognosis, it appears that physicians 
may focus on messages about the importance of treatment and follow-up in DCIS when 
communicating with LEP patients, rather than more positive and complex messages about 
the differences between DCIS and invasive cancer in terms of prognosis. Furthermore, 
Spanish-speaking Latina women may be less likely to ask questions to clarify their 
understanding, leading to poorer overall knowledge about their prognosis [21].
Importantly, we noted that despite the complexity of these discussions, only three Spanish-
speaking women in our study reported having a professional interpreter present during visits 
with their cancer physicians. Professional interpreters have been shown to improve patient 
outcomes and patient and physician satisfaction with care for LEP patients across a spectrum 
of conditions and clinical settings [22]. The absence of professional interpreters and the use 
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of ad hoc family and clinic staff not trained to interpret may have contributed to a more 
reductionist approach to communicating about risk and prognosis associated with DCIS 
[23]. Physicians likely focused on a discussion of risk and the need for treatment to prevent 
invasive disease. Furthermore, patients may not have had sufficient opportunity to ask 
questions. Moreover, according to National Culturally and Linguistically Appropriate 
Services (CLAS) Standards in Health and Health Care, providers who received federal 
funding are mandated to provide language assistance to LEP patients [24]. The mandate 
requires that patients are made aware of language services and further suggests that the use 
of untrained interpreters should be avoided. The lack of provision of trained interpreters is 
not only of utmost importance to patient care, but is also a federal mandate.
This study has limitations, most notably the fact that women were interviewed on average 
two years after their diagnosis, which may have led to inaccurate recall of events that 
occurred around treatment. While answers to the knowledge questions may not accurately 
describe knowledge at the time of diagnosis and treatment, it has been shown in other 
longitudinal studies that perception of risks related to breast cancer does not change over 
time [18, 25]. An additional limitation of this survey-based study is that we were not able to 
observe actual discussions about risk and prognosis between participants and their 
physicians and had to rely on self-reported data. Another limitation is the fact that only 60 % 
of eligible women completed the survey which could make the findings less generalizable. 
However, women from all geographic areas of California, representing a wide range of 
socio-demographics did participate. Despite these limitations, our findings do provide 
insight into the overall poor understanding of DCIS among those having gone through 
treatment for the disease and indicates a clear need for improved communication around 
presenting treatment options and prognosis.
Conclusion
In this multi-ethnic, multilingual study of women with a recent history of DCIS diagnosis 
and treatment, participants had greater knowledge of the worrisome risks conferred by DCIS 
than the nuances of DCIS as a non-life-threatening disease with a good prognosis. This 
knowledge imbalance was most marked for Spanish-speaking Latina women, and may be a 
reflection of physicians’ simplified communication with patients in the face of cultural and 
linguistic barriers. Culturally and linguistically appropriate standardized information about 
risks, treatment options, and prognosis would improve knowledge for all women diagnosed 
with DCIS. In particular, surgeons and oncologists treating LEP patients should be 
encouraged to use professionally trained interpreters to avoid overly simplified messages 
and promote more thorough information exchange.
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Table 1
Description of the sample by language–ethnicity (N = 710)
English-speaking whites 
(N = 368) N (%)
English-speaking Latinas 
(N = 152) N (%)
Spanish-speaking Latinas 




  Less than high school 10 (3) 21 (14) 113 (60) < 0.0001
  High school/vocational graduate 71 (19) 51 (34) 37 (20)
  College or higher 285 (78) 78 (52) 38 (20)
 Insurance
  Public 65 (18) 36 (24) 102 (54) < 0.0001
  Private 303 (82) 116 (76) 88 (46)
 Age
  < 50 105 (29) 42 (28) 64 (34) 0.50
  50–64 173 (47) 70 (46) 89 (47)
  ≥65 90 (24) 40 (26) 37 (19)
 California Cancer Registry region
  Bay area 103 (28) 39 (26) 34 (18) 0.13
  Central and Sacramento 71 (19) 39 (26) 41 (22)
  L.A. and Tri-County 114 (31) 40 (26) 69 (36)
  Riverside and San Bernardino 48 (13) 25 (16) 27 (14)
  San Diego 32 (9) 9 (6) 19 (10)
Health history
 Treatment type
  Lumpectomy with radiation 179 (49) 90 (59) 101 (53) 0.01
  Lumpectomy, no radiation 72 (20) 14 (9) 22 (12)
  Mastectomy 117 (32) 48 (32) 67 (35)
 Family members with breast cancer
  Immediate relative 153 (42) 67 (44) 38 (20) < 0.0001
  Distant relative or none 215 (58) 85 (56) 152 (80)
Diagnostic information
 Obtained second opinion
  Yes 167 (46) 63 (41) 39 (21) < 0.0001
 Time since diagnosis
  Months, mean ± SD (range) 25 ± 8 (8–49) 23 ± 7 (9–43) 22 ± 8 (7–51) 0.0002
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Table 2
DCIS knowledge by language–ethnicity (N = 710)
English-speaking whites (N = 368) 
N (%)
English-speaking Latinas (N = 
152) N (%)
Spanish-speaking 
Latinas (N = 190) N 
(%)
p value
This type of breast problem is not itself life-threatening
 True 178 (48) 52 (34) 60 (32) 0.0005
 False 152 (41) 77 (51) 109 (57)
 Unsure 38 (10) 23 (15) 21 (11)
Women with this type of breast problem have more chances of developing breast cancer in the future
 True 228 (62) 94 (62) 152 (80) < 0.0001
 False 46 (13) 22 (14) 5 (3)
 Unsure 94 (26) 36 (24) 33 (17)
If untreated, this type of breast problem can become invasive cancer
 True 344 (93) 140 (92) 169 (89) 0.17
 False 8 (2) 4 (3) 3 (2)
 Unsure 16 (4) 8 (5) 18 (9)
The chances of dying from the breast problem are the same for women who have a mastectomy and for 
those who have a lumpectomy with radiation
 True 108 (29) 51 (34) 70 (37) < 0.0001
 False 124 (34) 35 (23) 29 (15)
 Unsure 136 (37) 66 (43) 91 (48)
Percentages may add to greater than 100 % due to rounding error
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Table 3
Multivariable logistic regression: DCIS knowledge (N = 710)
Not itself life- 
threatening OR (95 % 
CI)
More chances of future 
breast cancer OR (95 % 
CI)
If untreated, can 
become invasive OR (95 
% CI)
Mortality the same for 
mastectomy and for 
lumpectomy + radiation 
OR (95 % CI)
Language–ethnicity
 English white Reference Reference Reference Reference
 Latina English Latina 0.6 (0.4–0.9) 1.0 (0.6–1.4) 0.9 (0.4–1.8) 1.1 (0.7–1.7)
 Latina Spanish Latina 0.5 (0.3–0.9) 2.6 (1.6–4.4) 0.7 (0.3–1.6) 1.2 (0.7–1.9)
Treatment type
 Mastectomy Reference Reference Reference Reference
 Lumpectomy 1.2 (0.9–1.7) 1.0 (0.7–1.4) 0.9 (0.5–1.6) 1.0 (0.7–1.4)
All models also adjusted for family history of breast cancer, educational attainment, age, insurance, geographic region in California, time since 
diagnosis, and having sought out a second opinion
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